Last updated: August 4, 2026
Sponsor: KK Women's and Children's Hospital
Overall Status: Completed
Phase
3
Condition
Hives (Urticaria)
Skin Wounds
Rash
Treatment
Opioid administration oxycodone
Opioid administration morphine
Clinical Study ID
NCT02277678
2013/321/D
Ages 21-50 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
American Society of Anesthesiologists (ASA) physical status 1-2,
aged between 21 to 50 years undergoing a term elective caesarean section and
had consented for combined spinal-epidural (CSE) anaesthesia
Exclusion
Exclusion Criteria:
concurrent opioid therapy,
contraindications to CSE anaesthesia or any of the study medications,
a history of pre-existing nausea and vomiting,
failure to identify intrathecal space at time of anaesthesia,
inadvertent dural puncture with the epidural needle and
conversion of regional anaesthesia to general anaesthesia
Study Design
Total Participants: 100
Treatment Group(s): 2
Primary Treatment: Opioid administration oxycodone
Phase: 3
Study Start date:
August 01, 2013
Estimated Completion Date:
December 31, 2014